Drug Shortage Report for MYLAN-BUPRENORPHINE/NALOXONE

Last updated on 2019-09-18 History
Report ID 7392
Drug Identification Number 02408090
Brand name MYLAN-BUPRENORPHINE/NALOXONE
Common or Proper name BUPRENORPHINE/NALOXONE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) BUPRENORPHINE NALOXONE
Strength(s) 2MG 0.5MG
Dosage form(s) TABLET
Route of administration SUBLINGUAL
Packaging size 100BT
ATC code N07BC
ATC description DRUGS USED IN ADDICTIVE DISORDERS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-07-03
Actual start date 2018-06-26
Estimated end date Unknown
Actual end date 2019-09-17
Shortage status Resolved
Updated date 2019-09-18
Company comments discontinued in ID 94044. Last lot 3085355 exp 2019-05-31
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v123 2018-03-23 French Compare
v122 2018-03-23 English Compare
v121 2018-03-21 French Compare
v120 2018-03-21 English Compare
v119 2018-03-19 French Compare
v118 2018-03-19 English Compare
v117 2018-03-13 French Compare
v116 2018-03-13 English Compare
v115 2018-03-09 French Compare
v114 2018-03-09 English Compare
v113 2018-03-07 French Compare
v112 2018-03-07 English Compare
v111 2018-03-06 French Compare
v110 2018-03-06 English Compare
v109 2018-03-06 English Compare
v108 2018-03-05 French Compare
v107 2018-03-05 English Compare
v106 2018-03-05 French Compare
v105 2018-03-05 English Compare
v104 2018-03-01 French Compare

Showing 21 to 40 of 143